# PHYRAGO

NDC: 70709-151
Generic name: dasatinib
Labeler / Manufacturer: Cycle Pharmaceuticals Ltd
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20250922

FDA application: NDA216099

## Active ingredients

- DASATINIB: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70709-151"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70709-151
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=60976d1e-c415-417f-8168-4e07999a7281